So , what have I missed ?
Safty ?
Its not a bad problem as if it was the trial would be stoped how ever the way the results are put together the patients that have had a advers advent could significatly effect the headline result. I am not disputing the headline result. It is good.
Before the claim " the cells work" can be made
( somthing all investors would like to see) a change in the trial desighn is needed.
Treat the control with the same unseeded dressing and enroll a lot more patients as the dressing without been seeded could provide most of this benefit. To carry on as planed is waisting time and money.
So , what have I missed ?Safty ? Its not a bad problem as if it...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $60.17M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 31.5¢ | $22.67K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7864 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.57pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.015 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 33.0¢ | 31.5¢ | 20409 | ||
| Last updated 15.48pm 31/05/2024 ? | |||||
| CYP (ASX) Chart |